[Funding alert] Biotech Startup Vgenomics Secures Seed Funding From Mumbai Angels, Others

The biotech and healthcare startup Vgenomics secured an undisclosed sum in a seed round headed by O2 Angel Network and Mumbai Angels.

Renowned angel investors like Sabine Kapasi and Rohit Chanana actively participated in the round as well.

Read also - [Funding alert] Wellness Startup Zingavita Secures Rs 10 Cr Pre-Series A Funding Led by Anicut Capital

The funding will be used by the company to develop medical solutions and grow its current clientele of gynaecologists, clinical geneticists, neonatologists, and paediatricians, as reported by bw disrupt.

Nandini Mansinghka, CEO of Mumbai Angels shared her thoughts. “Vgenomics’ groundbreaking approach to harnessing next-generation, AI -powered sequencing technologies to address rare diseases is commendable. We believe this investment not only validates their innovative strategy but also propels the journey towards impacting the lives of millions of children affected by rare diseases worldwide.”

Read also - [Funding alert] NBFC InPrime Secures $3 Mn Equity Funding Led by Matrix Partners India

Their team comprises scientists, bioinformaticians, molecular biologists, and doctors from the USA and India. They have published more than 150 US patents, 200 academic articles, and over 30 years of combined expertise. Additionally, they offer customised solutions for clinical research, bioinformatics data processing, and genomic sequencing (WGS, WGS, RNA-seq, metagenome, etc.).

About Vgenomics

The company, which was started by Rahila Sardar, Preeti Gupta Lal, and several female scientists, develops diagnostic and therapeutic solutions for inborn diseases.

Read also - Ayurvedic Startup T.A.C Appoints Sanjiv Gupta as its Chief Advisor